Clindamycin hydrochloride Good Manufacturer supply High Quality 21462-39-5
- Molecular Formula:C18H33ClN2O5S.HCl
- Molecular Weight:461.45
- Appearance/Colour:white crystalline powder
- Vapor Pressure:1.79E-19mmHg at 25°C
- Melting Point:141 °C
- Boiling Point:647 °C at 760 mmHg
- Flash Point:345.1 °C
- PSA：127.56000
- Density:==
- LogP:1.52030
Clindamycin hydrochloride (21462-39-5) Usage
Clindamycin hydrochloride is a semi-synthetic lincosamide antibiotic derived from lincomycin. It is a white solid with a macrolide chemical structure. The hydrochloride salt forms at the basic N-ethylproline moiety and is the preferred pharmaceutical formulation. Clindamycin hydrochloride exhibits broad-spectrum antibiotic activity, particularly against anaerobic bacteria and protozoans, by binding to the 23S ribosomal subunit and blocking protein synthesis.
How to get the best price on Clindamycin hydrochloride?
Zibo Hangyu Biotechnology Development Co., Ltd is a quality supplier and manufacturer of Clindamycin hydrochloride . You can buy high quality, low price Clindamycin hydrochloride 21462-39-5 here.
Zibo Hangyu Biotechnology Development Co., Ltd. is a comprehensive chemical enterprise focusing on fine chemical products and pharmaceutical intermediates, integrating research and development, production and sales. The company is equipped with advanced equipment quality inspection and research center. At the same time, the company has excellent talents with rich experience in process development and quality control. To provide customers with total solutions from raw material processing to chemical synthesis systems. The company has established a standardized and perfect quality standard system to provide stable and high quality production and service.
Milestones
- 2012yearThe company was founded, began to engage in the production and supply of chemical raw materials
- 2014yearExpand the scale of production, pharmaceutical raw materials production workshop was established
- 2016yearCooperated with domestic and foreign chemical platforms to promote self-produced and high-end pharmaceutical intermediates
- 2019yearIn recent years to participate in the international pharmaceutical raw materials exhibitions
- 2023yearBusiness continues to expand, Production and Sales teams continue to grow
- 2026yearPlans to set up foreign branches
